Ny presentation från Stora Aktiedagen Stockholm den 25 Nov

2019-11-28 10:38

Ny presentation från Stora Aktiedagen Stockholm den 25 Nov

VD Thomas Warthoe kommer att presentera Qlife på Stora Aktiedagen i Stockholm den 25/11. Vill ni läsa mer om dagarnas hela program och anmälan, se bifogad anmälan.

2024-09-10 09:00

Qlife is pleased to announce that Peter Warthoe will return to the management group as Chief Scientific Officer

2024-09-06 13:03

Qlife Holding AB (publ) is pleased to announce that it publishes a second balance sheet for liquidation purposes showing that the Company's total equity exceeds the registered share capital

2024-09-04 09:00

Production of Egoo consumables now established in China to support on-going clinical trials and future sales

2024-08-29 22:44

Qlife provides strategic business update and plans rebranding as 'Egoo Health' – a new era begins

2024-08-29 22:33

Qlife acquires the assets of Qlife ApS, carries out directed issues of a total of approx. MSEK 6.90 and proposal of directed issues of approx. MSEK 5.05

2024-08-29 08:00

QLIFE HOLDING AB, Interim Report Q2, April to June 2024

2024-08-01 16:00

Qlife Holding AB (publ) meddelar omräkning av teckningsoptioner

2024-07-19 09:10

Qlife Holding AB’s subsidiary Qlife ApS terminates corporate restructuring and files for bankruptcy. Qlife Holding AB investigates a capital raise and to submit an offer to repurchase the assets.

2024-07-17 17:44

Avstämningsdag för sammanläggning av aktier i Qlife Holding AB